TD Asset Management

TD Asset Management Portfolio holdings

AUM $117B
This Quarter Return
-0.44%
1 Year Return
+25.17%
3 Year Return
+87.06%
5 Year Return
+156.45%
10 Year Return
+305.53%
AUM
$109B
AUM Growth
+$109B
Cap. Flow
-$1.04B
Cap. Flow %
-0.96%
Top 10 Hldgs %
24.54%
Holding
1,291
New
49
Increased
538
Reduced
573
Closed
75

Sector Composition

1 Financials 21.36%
2 Technology 19.34%
3 Industrials 10.57%
4 Healthcare 9.59%
5 Consumer Discretionary 7.87%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
CRBP icon
1226
Corbus Pharmaceuticals
CRBP
$115M
-24,200 Closed -$286K
DAWN icon
1227
Day One Biopharmaceuticals
DAWN
$769M
-10,796 Closed -$137K
DBRG icon
1228
DigitalBridge
DBRG
$2.08B
-191,490 Closed -$2.16M
DINO icon
1229
HF Sinclair
DINO
$9.52B
-62,932 Closed -$2.21M
EYPT icon
1230
EyePoint Pharmaceuticals
EYPT
$797M
-62,946 Closed -$469K
FAF icon
1231
First American
FAF
$6.72B
-10,208 Closed -$637K
FIVE icon
1232
Five Below
FIVE
$8B
-274,910 Closed -$28.9M
FMC icon
1233
FMC
FMC
$4.88B
-22,030 Closed -$1.07M
GERN icon
1234
Geron
GERN
$893M
-154,614 Closed -$547K
HHH icon
1235
Howard Hughes
HHH
$4.53B
-27,644 Closed -$2.13M
HSTM icon
1236
HealthStream
HSTM
$832M
-6,400 Closed -$204K
IGMS
1237
DELISTED
IGM Biosciences
IGMS
-164,472 Closed -$1M
KNX icon
1238
Knight Transportation
KNX
$7.13B
-15,294 Closed -$811K
KOD icon
1239
Kodiak Sciences
KOD
$478M
-166,400 Closed -$1.66M
KRE icon
1240
SPDR S&P Regional Banking ETF
KRE
$3.99B
-16,493 Closed -$995K
KROS icon
1241
Keros Therapeutics
KROS
$618M
-51,600 Closed -$817K
KRP icon
1242
Kimbell Royalty Partners
KRP
$1.3B
-72,350 Closed -$1.17M
LAMR icon
1243
Lamar Advertising Co
LAMR
$12.9B
-50,492 Closed -$6.15M
LMAT icon
1244
LeMaitre Vascular
LMAT
$2.16B
-3,000 Closed -$276K
MGNX icon
1245
MacroGenics
MGNX
$112M
-43,400 Closed -$141K
MOD icon
1246
Modine Manufacturing
MOD
$7.15B
-24,990 Closed -$2.9M
MTDR icon
1247
Matador Resources
MTDR
$6.27B
-4,286 Closed -$241K
MYRG icon
1248
MYR Group
MYRG
$2.91B
-6,200 Closed -$922K
NGNE icon
1249
Neurogene
NGNE
$264M
-15,800 Closed -$361K
NMRA icon
1250
Neumora Therapeutics
NMRA
$280M
-68,418 Closed -$725K